SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2026)
SAB Biotherapeutics (SABS) reported Treasury Shares of $5.52 million for Q2 2026, unchanged from $5.52 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Treasury Shares (2022 - 2026) Analysis & Trends
Dating back to Q1 2022, SAB Biotherapeutics' Treasury Shares record includes 18 quarters.
- Treasury Shares has a three-year compound annual growth rate of 0.0% (FY2022 to FY2025).
- By year, Treasury Shares came in at $5.52 million in FY2024 (unchanged), $5.52 million in FY2023 (unchanged) and $5.52 million in FY2022.
- Five-year quarterly Treasury Shares spans a low of $5.52 million in Q4 2025 and a high of $5.52 million in Q1 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.52 million (Q1 2026), $5.52 million (Q4 2025) and $5.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.04 Bn | 1,100.62 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 614.86 Bn | 533.39 Bn | 17.26 Bn | 711.62 Mn |
| 3 | AbbVie | 503.32 Bn | 476.44 Bn | 12.70 Bn | 77.11 Mn |
| 4 | Merck | 367.14 Bn | 321.52 Bn | 12.21 Bn | 1.11 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 49.00 Mn |
| 6 | Astrazeneca | 261.69 Bn | 235.37 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.43 Bn | 191.82 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.71 Bn | 164.90 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 3.94 Bn |
| 10 | SAB Biotherapeutics | 230.09 Mn | -187.41 Mn | - | 54,665.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54,665.00 |
| Mar 31, 2026 | 54,665.00 |
| Dec 31, 2025 | 54,665.00 |
| Sep 30, 2025 | 54,665.00 |
| Jun 30, 2025 | 54,665.00 |
| Mar 31, 2025 | 54,665.00 |
| Dec 31, 2024 | 54,665.00 |
| Sep 30, 2024 | -54,665.00 |
| Jun 30, 2024 | -54,665.00 |
| Mar 31, 2024 | -54,665.00 |
| Dec 31, 2023 | -54,665.00 |
| Sep 30, 2023 | 546,658.00 |
| Jun 30, 2023 | 546,658.00 |
| Mar 31, 2023 | 546,658.00 |
| Dec 31, 2022 | 54,665.00 |
| Sep 30, 2022 | 546,658.00 |
| Jun 30, 2022 | 546,658.00 |
| Mar 31, 2022 | 546,658.00 |
API Access
SAB Biotherapeutics Treasury Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();